📰
Politics
Genmab Soars as Cancer Drug Impresses in a Late-Stage Trial
📅26 October 2026 at 10:01
📰Bloomberg
👁️3 views
Share:
📰
Article Preview
Genmab A/S shares surged the most in more than six years after its experimental ovarian cancer treatment exceeded analyst expectations in a late-stage trial, boosting confidence in the Danish drugmaker’s pipeline.
🎧
Listen to Preview
Audio version available
🔇
Audio Reader
Not supported in this browser
Want the full story?
Click below to load the complete article with full details, analysis, and context.
Share this story
Share:
Source: This article was originally published by Bloomberg. All rights reserved to the original publisher.
Comments
Loading comments...
Related Stories
Stay Updated
Get the latest Nigerian news delivered to your inbox.